Considering sex as a biological variable; new NIH requirement effective Jan. 2016

Women comprise slightly more than half of the population–and their representation is relatively well balanced in NIH-sponsored clinical research, where they now account for roughly half of all participants. But this shift has not occurred in the preclinical realm. Today, most NIH-sponsored animal studies are focused on males, and many investigators do not report on the sex of the subjects from whom cells are obtained for cell line work. This lack of balance may obscure … Read More

New Science paper from the Skach Lab sheds light on protein folding

A recent paper published in Science may change how we think about how protein folding in its endogenous context.  For the past 50 years, the principles by which proteins unfold and refold have been studied largely using purified recombinant substrates.  Under these experimental conditions, however, it has been extraordinarily difficult to examine how a protein folds in its native environment.  To address this question, the Skach Lab developed a novel technique that uses fluorescence resonance … Read More

NIGMS wants to hear from you!

The National Institute of General Medical Sciences examining innovative ways to best support biomedical researchers. Last week we reported on NIGMS’s new funding mechanism for early-career scientists and now they’re seeking input on how best to foster technology development for the research community. More specifically, the Institute is asking for information on the need for development of technologies and the relationship of technology development to other biomedical research. Of particular interest are ideas about: The value … Read More

Michael Cohen, Ph.D., named Pew Scholar

Hot off last week’s Industry Spotlight comes more news about Michael Cohen: he has been named to the 2015 class of Pew Scholars. The Pew Scholars are selected each year by the Pew Charitable Trusts–the program supports the research of young investigators who demonstrate exceptional potential in biomedical research.  This important award reflects Cohen’s promise as a researcher and innovator. His research concerns how ADP-ribosyltransferases affect learning, memory, and other brain functions. He is engineering these … Read More

NRSA Application Workshop: Technical Components, June 30

If you’re planning to apply for a pre- or post-doctoral NRSA fellowship from the NIH in the near future, we encourage you to attend this workshop to learn about essential, non-research elements of your fellowship application. Topics covered include elements needed for an InfoEd proposal, how to develop a budget, how to manage reference letters, biosketches and PMCID numbers,and elements of a great training plan. This workshop is led by Johanna Colgrove, M.D., Ph.D., program coordinator; Jerry … Read More

National Institute of General Medical Sciences announces new funding mechanism for early-career scientists

Earlier this week, NIGMS announced a new funding mechanism for early-career researchers–the MIRA, for Maximizing Investigators’ Research Award for New and Early Stage Investigators (R35). This mechanism is intended to support scientists, rather than specific projects.  It’s a bit of an experiment for NIGMS, so they are limiting eligible applicants to NIH-defined Early Stage Investigators and New Investigators at the assistant professor rank or equivalent (postdocs on K99s are not eligible; but if you have … Read More

Mining the funding data: two more important analyses of NIH trends

Is it true that NIH funding is a) really declining and b) driving scientists out of research? Two new analyses show that both appear to be true. DataHound has been using R to sort out whether the number of unique PIs declined from 1985-2014 and whether having a K99 gave postdocs any funding traction in subsequent years. He also looked more broadly at all contact PIs. Drugmonkey sums up his findings in more detail, but basically … Read More

Join us tomorrow for May’s Funding Focus – Understanding Foundation Funding

Are you familiar with NIH funding but not sure where to start when it comes to foundations? Maybe you need seed funding for a new project or you’re planning a conference and could use help finding corporate sponsors. Join us for May’s Funding Focus seminar, Understanding Foundation Funding on: Thursday, May 21 12 to 1 p.m.  Mackenzie Hall 2201 We’ll cover: Key differences between government and private funding How to target your research proposal to a specific … Read More

The National Heart, Lung, and Blood Institute seeks input on research priorities

The National Heart, Lung, and Blood Institute (NHLBI) is looking for input from scientists–and the public–to help shape its funding priorities. If you’re funded by NHLBI, or hope to be, or if you benefit from the several hundred million dollars per year that they spend on biomedical research–in short, if you are living and breathing, this is your opportunity to shape the research of the future. Specifically, they want to identify the most compelling questions … Read More

Funding Focus this Thursday, Apr. 16 – New Ways of Finding Funding

This is a reminder to join us for April’s Funding Focus seminar to learn New Ways of Finding Funding at OHSU. The seminar will be held from 12 to 1 p.m. on Thursday, Apr. 16, in Mackenzie Hall 2201. We’ll be discussing: GrantScoop – a newly acquired software tool for identifying both private and government funding opportunities. GrantScoop is specifically designed for research scientists seeking grant funding and allows for selective searches with extensive filtering … Read More

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.